Загрузка...
Lithium use in a patient on haemodialysis with bipolar affective disorder and lithium-induced nephropathy
Lithium is an effective mood stabiliser used to treat bipolar affective disorder (BPAD); however, it can also adversely affect the kidneys, causing acute toxic effects, nephrogenic diabetes insipidus, chronic renal dysfunction and end-stage kidney disease (ESKD) in a minority of patients. We describ...
Сохранить в:
| Опубликовано в: : | BMJ Case Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8327746/ https://ncbi.nlm.nih.gov/pubmed/34330723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2021-242841 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|